Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin.

Ross EA, Smallie T, Ding Q, O'Neil JD, Cunliffe HE, Tang T, Rosner DR, Klevernic I, Morrice NA, Monaco C, Cunningham AF, Buckley CD, Saklatvala J, Dean JL, Clark AR.

J Immunol. 2015 Jul 1;195(1):265-76. doi: 10.4049/jimmunol.1402826. Epub 2015 May 22.

2.

NF-κB-induced KIAA1199 promotes survival through EGFR signalling.

Shostak K, Zhang X, Hubert P, Göktuna SI, Jiang Z, Klevernic I, Hildebrand J, Roncarati P, Hennuy B, Ladang A, Somja J, Gothot A, Close P, Delvenne P, Chariot A.

Nat Commun. 2014 Nov 4;5:5232. doi: 10.1038/ncomms6232.

3.

Regulation of the activity and expression of ERK8 by DNA damage.

Klevernic IV, Martin NM, Cohen P.

FEBS Lett. 2009 Feb 18;583(4):680-4. doi: 10.1016/j.febslet.2009.01.011. Epub 2009 Jan 21.

4.

Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage.

Klevernic IV, Morton S, Davis RJ, Cohen P.

Biochem J. 2009 Mar 15;418(3):625-34. doi: 10.1042/BJ20082097.

PMID:
19076070
5.

The selectivity of protein kinase inhibitors: a further update.

Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P.

Biochem J. 2007 Dec 15;408(3):297-315.

6.

Characterization of the reversible phosphorylation and activation of ERK8.

Klevernic IV, Stafford MJ, Morrice N, Peggie M, Morton S, Cohen P.

Biochem J. 2006 Feb 15;394(Pt 1):365-73.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk